Search Results
Aug 07, 2026, 17:06 ET Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-bow-atkr-supn-obtaining-fair-deals-for-their-shareholders-302846304.htmlSOURCE
More news about: Halper Sadeh LLP
Aug 03, 2026, 15:13 ET $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)
SUPN) related to its sale to Indivior Pharmaceuticals, Inc. Under the terms of the proposed transaction, Supernus shareholders are expected to receive
More news about: Monteverde & Associates PC
Aug 03, 2026, 13:41 ET Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-supn-itgr-atkr-lnth-obtaining-fair-deals-for-their-shareholders-302841372.htmlSOURCE
More news about: Halper Sadeh LLP
Aug 03, 2026, 11:41 ET Shareholder Alert: Ademi LLP investigates whether Supernus Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, Aug. 3, 2026 /PRNewswire/ -- Ademi LLP is investigating Supernus (Nasdaq: SUPN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Indivior Pharmaceuticals.
More news about: Ademi LLP
Feb 09, 2026, 11:14 ET Lunai Bioworks, Inc. Issues Letter to Shareholders
the related genes and then discovers potential drugs of interest and test them in living systems. We did this for Supernus Pharmaceuticals (NASDAQ: SUPN) by identifying the right epilepsy subgroup for their lead candidate (SPN_817) phase 2 clinical trial. We have recently announced three distinct types
More news about: Lunai Bioworks Inc.